KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Amortization of Deferred Charges (2017 - 2025)

Emergent BioSolutions' Amortization of Deferred Charges history spans 9 years, with the latest figure at $2.6 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 18.18% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $9.8 million, up 32.43%, while the annual FY2025 figure was $9.8 million, 32.43% up from the prior year.
  • Amortization of Deferred Charges reached $2.6 million in Q4 2025 per EBS's latest filing, up from $2.5 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $8.9 million in Q2 2023 to a low of -$6.7 million in Q3 2024.
  • Average Amortization of Deferred Charges over 5 years is $2.3 million, with a median of $1.6 million recorded in 2021.
  • Peak YoY movement for Amortization of Deferred Charges: soared 790.0% in 2023, then plummeted 217.54% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $1.0 million in 2021, then fell by 0.0% to $1000000.0 in 2022, then soared by 470.0% to $5.7 million in 2023, then plummeted by 61.4% to $2.2 million in 2024, then rose by 18.18% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Amortization of Deferred Charges are $2.6 million (Q4 2025), $2.5 million (Q3 2025), and $2.4 million (Q2 2025).